A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe

Allgemeines Krankenhaus Der Stadt Wien (General Hopsital), Universitätsklinik Für Innere Medizin I Klinische Abteilung Für Onkologie (Clinic of Internal Medicine I), Medizinische Universität Wien, Vienna

University Hospital Ostrava, Clinic of Hematooncology, Ostrava

Centre Hospitalier Universitaire de Limoges, Department of Clinical Hematology and Cell Therapy, Limoges

Service de Néphrologie, Hémodialyse Et Transplantation Rénale, Hôpital Jean Bernard, Chu Poitiers, Poitiers

Universität Heidelberg, Department of Internal Medicine V: Hematology, Oncology and Rheumatology, Heidelberg

Alexandra Hospital, University of Athens School of Medicine, Department of Clinical Therapeutics, Athens

Centro Per Lo Studio E La Cura Delle Amiloidosi Sistemiche Padiglione Forlanini, Pavia

University Medical Center Groningen, Groningen

University Medical Center Utrecht, Umc Utrecht, Department of Hematology, Utrecht

Fundação Champalimaud, Hematology Research, Imunology - Medical School, Nova University, Lisbon

Centro Hospitalar E Universitário São João, Porto

Servicio de Hematología, Hospital Clínic de Barcelona, Barcelona

University College London Medical School, Uk Royal Free Hospital, London